Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neurology

Recognizing the Signs: Why FTD is Often Misdiagnosed

At a Glance

Frontotemporal dementia (FTD) usually begins with significant changes in behavior, personality, or language skills, rather than memory loss. Because these symptoms can mimic depression, bipolar disorder, or a midlife crisis, FTD is often misdiagnosed in its early stages.

Because frontotemporal dementia (FTD) often begins with changes in personality or language rather than memory, it is frequently misunderstood by both families and medical professionals [1][2]. Understanding the specific “footprint” of FTD symptoms—and why they differ from other conditions—is the first step toward getting the right care.

How FTD Symptoms Differ from Alzheimer’s

In the early stages of Alzheimer’s disease, the most prominent symptom is usually short-term memory loss (e.g., forgetting appointments or repeating questions) [3]. In contrast, memory often remains relatively intact in early FTD [4]. Instead, the disease attacks the brain’s “executive” and “social” centers.

  • Disinhibition: A person may lose their “social filter,” making inappropriate comments, acting impulsively, or showing a lack of basic manners [3][5].
  • Apathy: This is one of the most common early signs. It may look like depression, but it is actually a profound loss of motivation or interest in things the person once cared about [3][4].
  • Loss of Empathy: You may notice a “blunting” of emotions. A person who was once warm and caring may seem indifferent to the feelings or needs of others [6][7].
  • Language Struggles: In variants called Primary Progressive Aphasia (PPA), the first sign is a persistent difficulty in finding words, naming objects, or understanding conversations [8][9].
  • Anosognosia: This is a medical term for a “lack of insight.” Unlike people with early Alzheimer’s, who may be frustrated by their memory slips, people with FTD are often completely unaware that their behavior has changed and may be indifferent to the concerns of family members [10][11].

The Challenge of Misdiagnosis

FTD is a “master of disguise” in the clinical world. Because it often strikes people in their 40s and 50s, doctors may not initially consider dementia [1].

Common misdiagnoses include:

  • Psychiatric Disorders: Because symptoms like apathy and withdrawal look like depression, or impulsivity looks like bipolar disorder, many patients are initially treated for psychiatric conditions [12][13]. In some cases, FTD can even mimic the symptoms of schizophrenia or catatonia [14][15].
  • Alzheimer’s Disease: Many clinicians default to an Alzheimer’s diagnosis simply because it is the most well-known form of dementia, even when the person’s memory is still strong [3].
  • Midlife Crisis: Families often interpret early personality changes as a marital issue, work stress, or a “midlife crisis” before realizing a medical condition is responsible.

Why an Accurate Diagnosis Matters

Getting the right name for the condition is vital for several reasons:

  1. Medication Safety: People with FTD can have severe, adverse reactions to certain medications, such as traditional antipsychotics, which are sometimes prescribed for behavioral issues [16][17].
  2. Effective Management: While memory-enhancing drugs used for Alzheimer’s often do not help FTD symptoms, other treatments like serotonergic antidepressants may help manage mood and behavioral shifts [18].
  3. Future Planning: FTD has a strong genetic component (30-50% of cases). An accurate diagnosis allows families to pursue genetic counseling and plan for the specific needs of an FTD progression [19].

New diagnostic tools, including blood biomarkers (like p-tau181 and Neurofilament Light Chain/NfL) and specialized clinical rating scales (CDR plus NACC FTLD), are helping doctors distinguish FTD from other conditions more accurately than ever before [20][21][22]. Learn more about these tools in The Biology of FTD.

Common questions in this guide

What are the very first signs of frontotemporal dementia?
The earliest signs of FTD typically involve changes in personality, behavior, or language rather than memory loss. You may notice a loved one acting impulsively, losing interest in hobbies, showing a lack of empathy, or struggling to find the right words.
Why is FTD frequently misdiagnosed?
FTD is often misdiagnosed because it frequently strikes people in their 40s and 50s, leading doctors to suspect a psychiatric condition like depression, bipolar disorder, or a midlife crisis. Additionally, because Alzheimer's is more widely known, clinicians may default to it even if the patient's memory is still intact.
How is FTD different from Alzheimer's disease?
In early Alzheimer's, short-term memory loss is usually the most prominent symptom, and patients are often aware of and frustrated by it. In early FTD, memory typically remains strong, but the disease causes major shifts in behavior, mood, and communication, which the patient often does not notice.
What does lack of insight mean in FTD?
Lack of insight, medically known as anosognosia, means the person with FTD is completely unaware that their behavior or personality has changed. They cannot see the shifts in their own actions and may seem entirely indifferent to the concerns raised by their family members.
Why is getting an accurate FTD diagnosis so important?
An accurate diagnosis is crucial because certain medications used for psychiatric conditions, like traditional antipsychotics, can cause severe side effects in people with FTD. It also allows families to find the right behavioral management strategies and pursue genetic counseling if needed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the symptoms we are seeing, why do you suspect FTD rather than a primary psychiatric condition like late-onset bipolar disorder or depression?
  2. 2.Can we perform specialized testing for anosognosia (lack of insight), and how does that help confirm an FTD diagnosis?
  3. 3.Are there specific 'red flag' behavioral symptoms, such as disinhibition or hyperorality (changes in eating habits), that you are looking for to differentiate this from Alzheimer's?
  4. 4.If we are considering a psychiatric medication, are there specific classes like traditional antipsychotics that we should avoid due to potential side effects in FTD patients?
  5. 5.What diagnostic markers—such as plasma p-tau181 or neurofilament light chain (NfL)—are available to help distinguish between FTD and Alzheimer's pathology?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.

    Boxer AL, Gold M, Feldman H, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):131-143 doi:10.1016/j.jalz.2019.06.4956.

    PMID: 31668596
  2. 2

    Understanding Frontotemporal Disease Progression and Management Strategies.

    Mulkey M

    The Nursing clinics of North America 2019; (54(3)):437-448 doi:10.1016/j.cnur.2019.04.011.

    PMID: 31331629
  3. 3

    Diminished preparatory physiological responses in frontotemporal lobar degeneration syndromes.

    Chen KH, Hua AY, Toller G, et al.

    Brain communications 2022; (4(2)):fcac075 doi:10.1093/braincomms/fcac075.

    PMID: 35441132
  4. 4

    The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

    Ossenkoppele R, Pijnenburg YA, Perry DC, et al.

    Brain : a journal of neurology 2015; (138(Pt 9)):2732-49 doi:10.1093/brain/awv191.

    PMID: 26141491
  5. 5

    Diagnosing, monitoring and managing behavioural variant frontotemporal dementia.

    Piguet O, Kumfor F, Hodges J

    The Medical journal of Australia 2017; (207(7)):303-308 doi:10.5694/mja16.01458.

    PMID: 28954617
  6. 6

    Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia.

    Younes K, Borghesani V, Montembeault M, et al.

    Brain : a journal of neurology 2022; (145(11)):4080-4096 doi:10.1093/brain/awac217.

    PMID: 35731122
  7. 7

    Musicality and social cognition in dementia: clinical and anatomical associations.

    van 't Hooft JJ, Hartog WL, Braun M, et al.

    Brain communications 2024; (6(6)):fcae429 doi:10.1093/braincomms/fcae429.

    PMID: 39678365
  8. 8

    Genetic screen in a large series of patients with primary progressive aphasia.

    Ramos EM, Dokuru DR, Van Berlo V, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2019; (15(4)):553-560 doi:10.1016/j.jalz.2018.10.009.

    PMID: 30599136
  9. 9

    Neuropsychiatric Aspects of Frontotemporal Dementia.

    Younes K, Miller BL

    The Psychiatric clinics of North America 2020; (43(2)):345-360 doi:10.1016/j.psc.2020.02.005.

    PMID: 32439026
  10. 10

    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.

    Arroyo-Anlló EM, Bouston AT, Fargeau MN, et al.

    Journal of Alzheimer's disease : JAD 2017; (55(4)):1437-1443 doi:10.3233/JAD-160770.

    PMID: 27858712
  11. 11

    Anosognosia in degenerative brain diseases: The role of the right hemisphere and of its dominance for emotions.

    Gainotti G

    Brain and cognition 2018; (127()):13-22 doi:10.1016/j.bandc.2018.08.002.

    PMID: 30179807
  12. 12

    Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes.

    Fieldhouse JLP, van Engelen ME, Handgraaf D, et al.

    European journal of neurology 2024; (31(12)):e16426 doi:10.1111/ene.16426.

    PMID: 39171655
  13. 13

    The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.

    Peet BT, Castro-Suarez S, Miller BL

    Advances in experimental medicine and biology 2021; (1281()):17-31 doi:10.1007/978-3-030-51140-1_2.

    PMID: 33433866
  14. 14

    Frontotemporal dementia with trans-activation response DNA-binding protein 43 presenting with catatonic syndrome.

    Watanabe R, Kawakami I, Onaya M, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2018; (38(3)):281-287 doi:10.1111/neup.12442.

    PMID: 29110334
  15. 15

    When you hear hoofbeats, think horses and zebras: The importance of a wide differential when it comes to frontotemporal lobar degeneration.

    Nathani M, Jaleel V, Turner A, et al.

    Asian journal of psychiatry 2020; (47()):101875 doi:10.1016/j.ajp.2019.101875.

    PMID: 31775108
  16. 16

    The CBI-R detects early behavioural impairment in genetic frontotemporal dementia.

    Nelson A, Russell LL, Peakman G, et al.

    Annals of clinical and translational neurology 2022; (9(5)):644-658 doi:10.1002/acn3.51544.

    PMID: 35950369
  17. 17

    The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration.

    Perry A, Hughes LE, Adams N, et al.

    Translational psychiatry 2022; (12(1)):348 doi:10.1038/s41398-022-02114-6.

    PMID: 36030249
  18. 18

    Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.

    Buoli M, Serati M, Caldiroli A, et al.

    Journal of geriatric psychiatry and neurology 2017; (30(3)):162-169 doi:10.1177/0891988717700506.

    PMID: 28351199
  19. 19

    Predictors of survival in frontotemporal lobar degeneration syndromes.

    El-Wahsh S, Finger EC, Piguet O, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-324349.

    PMID: 33441385
  20. 20

    Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

    Thijssen EH, La Joie R, Wolf A, et al.

    Nature medicine 2020; (26(3)):387-397 doi:10.1038/s41591-020-0762-2.

    PMID: 32123386
  21. 21

    Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.

    Miyagawa T, Brushaber D, Syrjanen J, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):106-117 doi:10.1002/alz.12033.

    PMID: 31914218
  22. 22

    The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.

    Karantali E, Kazis D, Chatzikonstantinou S, et al.

    Aging clinical and experimental research 2021; (33(4)):869-881 doi:10.1007/s40520-020-01554-8.

    PMID: 32306372

This page provides educational information about frontotemporal dementia symptoms and diagnosis. It does not replace professional medical advice, diagnosis, or treatment from a qualified neurologist or healthcare provider.

Get notified when new evidence is published on Frontotemporal dementia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.